During the review, the committee will likely consider: The extensive body of published research on GHK-Cu (decades of studies) Safety data for both injectable and topical routes The clinical rationale for copper peptide therapy in anti-aging and wound healing Quality control considerations for compounding GHK-Cu formulations Public comments from patients, dermatologists, anti-aging practitioners, and pharmacies Given GHK-Cu's long history of use and substantial research base, many in the peptide therapy community are cautiously optimistic about a positive PCAC recommendation particularly for the topical route
Environmental sensitivity: protect from light and unnecessary temperature swings to help maintain integrity during storage
Some patients may require laboratory testing before treatment, while others may not
Dermatology Research and Practice , 2024, 8752787
Chicago, IL, USA: American Academy of Medicine
Research Use Disclaimer The compounds distributed by USA PEPTIDE SCIENCES , including GHK-Cu 1g raw topical-grade powder, are designated strictly for laboratory research purposes only